This article was reviewed by Knox Beasley, MD. Flakes on your scalp making you feel self-conscious? Let’s talk about seborrheic dermatitis vs dandruff. Whether your scalp feels like a snowglobe ...

Atopic dermatitis (AD) presents as a long-term, recurring inflammatory disorder of the skin, and its characteristic itching significantly affects patients' daily living standards. The research was ...

Atopic dermatitis is a chronic (long-lasting) skin condition that causes dry, itchy patches of skin that may crack or ooze. It is the most common form of eczema. Itchiness occurs when an ...

A medical research team has confirmed that ultrafine bubble showers significantly suppress inflammation in mice with atopic dermatitis due to external factors. Bubble baths might be soothing soaks ...

Paraneoplastic Pemphigus (PNP) may show interface dermatitis (one of the first Anhalt criteria ... In both diseases there is an eosinophilic inflammatory infiltrate, but also eosinophilic spongiosis, ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition. A better understanding of inflammation and lung immunity over the past two ...

Throw dermatitis into the mix, and the frustration compounds. No one wants to go about the day dealing with an uncomfortable, itchy rash. Dermatitis refers to a number of skin conditions driven ...

This accomplishment underscores the drug's effectiveness across various indications, particularly in atopic dermatitis (AD), where it is widely regarded as the gold standard (1 Trusted ...

We might be looking at contact dermatitis as a probable culprit. However, don’t be upset—we have listed down tips for quick recovery and five preventive measures. To gain insights, the ...

Dec. 17, 2024 -- The FDA last week approved Nemluvio for treating moderate to severe atopic dermatitis, a type of eczema, in people aged 12 or older. Nemluvio is to be used with topical ...

Chronic neutrophilic leukemia is a rare blood cancer characterized by the overproduction of mature neutrophils, a type of white blood cell. Currently, no standard treatment exists, but emerging ...

The FDA has approved lebrikizumab (Ebglyss; Eli Lilly) as a new first-line biologic treatment for patients aged 12 and older with moderate to severe atopic dermatitis (AD). The FDA approved ...